Skip to main content
 logo

Content

Top Menu

  • Contact Us
  • About Novelion
    • Leadership Team
    • News
    • Aegerion Pharmaceuticals
  • Products & Pipeline
  • Physician Resources
    • Global Medical Information
    • Expanded Access Program
    • Clinical Programs
    • Grants & IIS
    • EU Payment Disclosures
  • Careers
    • Employee Voices
    • Apply Online
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
      • SEDAR Filings
      • SEDI Filings
      • Annual Reports and Proxies
      • Key Ratios
      • 8937-original
      • 8937-amended
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
      • Ownership Profile
    • Shareholder Services
      • Investor FAQs
      • 2016 PFIC Letter
      • Aralez Distribution Form 8937
      • Contact Us
  • About Novelion
    • Leadership Team
    • News
    • Aegerion Pharmaceuticals
  • Products & Pipeline
  • Physician Resources
    • Global Medical Information
    • Expanded Access Program
    • Clinical Programs
    • Grants & IIS
    • EU Payment Disclosures
  • Careers
    • Employee Voices
    • Apply Online
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
      • SEDAR Filings
      • SEDI Filings
      • Annual Reports and Proxies
      • Key Ratios
      • 8937-original
      • 8937-amended
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
      • Ownership Profile
    • Shareholder Services
      • Investor FAQs
      • 2016 PFIC Letter
      • Aralez Distribution Form 8937
      • Contact Us
  • Contact Us
  • Locations
    • Location 1
    • Location 2

Financials & Filings

In This Section

  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • SEC Filings
    • SEDAR Filings
    • SEDI Filings
    • Annual Reports and Proxies
    • Key Ratios
    • 8937-original
    • 8937-amended
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Dividend History
    • Analyst Coverage
    • Ownership Profile
  • Shareholder Services
    • Investor FAQs
    • 2016 PFIC Letter
    • Aralez Distribution Form 8937
    • Contact Us
Home // Investors // Financials & Filings
Proxy Statements
Title View
May 1, 2017 HTML PDF XLS
Add to Briefcase File is in Briefcase
Form 10-K
Date Filed View
Mar 16, 2018 HTML PDF XLS XBRL Add to Briefcase File is in Briefcase
Mar 30, 2017 HTML PDF XLS XBRL Add to Briefcase File is in Briefcase
Form 10-Q
Date Filed View
Nov 9, 2017 HTML PDF XLS XBRL Add to Briefcase File is in Briefcase
Aug 8, 2017 HTML PDF XLS XBRL Add to Briefcase File is in Briefcase
= add PDF file to Briefcase
  • share
  • briefcase
  • downloads
  • email alerts
  • snapshot
  • printed docs
  • rss news feeds
  • print page

  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • Email
  • RSS

  • Home
  • Terms of Use
  • Privacy Policy

This page is intented exclusively for U.S. audiences.

© 2018 Novelion Therapeutics Inc.
All rights reserved. AEGR/Global/167 07-14